Endoscopic management of biliary tract disease

Current Opinion in Gastroenterology

Volumn 17, Issue 5, 2001, Pages 468-473

  Shah, Janak N ^a   Kochman, Michael L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABEXATE MESILATE; INTERLEUKIN 10; OCTREOTIDE; SOMATOSTATIN;

BILIARY TRACT DISEASE; BILIARY TRACT ENDOSCOPY; CLINICAL TRIAL; COMMON BILE DUCT STONE; DIAGNOSTIC IMAGING; DRUG EFFICACY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; HUMAN; LIVER TRANSPLANTATION; META ANALYSIS; NON INVASIVE MEASUREMENT; NONHUMAN; PANCREATITIS; PERFORATION; POSTOPERATIVE COMPLICATION; RADIODIAGNOSIS; REVIEW; STENT;

EID: 0034872488     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200109000-00012     Document Type: Review

References (59)

1. Common bile duct exploration in the era of laparoscopic cholecystectomy
2. Options and strategies for the management of choledocholithiasis
3. Management of gallstone cholangitis in the era of laparoscopic cholecystectomy
4. Long-term outcome of endoscopic papillotomy for choledocholithiasis with cholecystolithiasis
5. Long-term consequence of endoscopic sphincterotomy for bile duct stones
6. Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis: Multivariate analysis of prognostic factors for the recurrence of biliary symptoms
7. Additional endoscopic procedures instead of urgent surgery for retained common bile duct stones
8. Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients
9. Biliary stenting for management of common bile duct stones
10. Common bile duct stones become smaller after endoscopic billiary stenting
11. Pigtail stents: An alternative in the treatment of difficult bile duct stones
12. Treatment of difficult bile duct stones using mechanical, electrohydraulic, and extracorporeal shock wave lithotripsy
13. Fragmentation of gallstones with extracorporeal shock waves
14. Extracorporeal shock wave lithotripsy for clearance of bile duct stones resistant to endoscopic extraction
15. Clearance of refractory bile duct stones with extracorporeal shockwave lithotripsy
16. Ultrasound of the common bile duct in patients undergoing cholecystectomy
17. Endoscopic ultrasonography for diagnosing choledocholithiasis: A prospective comparative study with ultrasonography and computed tomography
18. Detection of choledocholithiasis: Comparison of unenhanced helical CT and endoscopic retrograde cholangiopancreatography
19. Magnetic resonance cholangiography: Comparison to endoscopic retrograde cholangiopancreatography
20. Choledocholithiasis: Evaluation with MR cholangiography
21. Diagnosing bile duct stones: Comparison of unenhanced helical CT, oral contrast-enhanced CT cholangiography, and MR cholangiography
22. Complications of endoscopic biliary sphincterotomy
23. Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study
24. Complications of diagnostic and therapeutic ERCP: A prospective multicenter study
25. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: A randomized multi-center placebo-controlled, clinical trial
26. Use of corticosteroids in the prevention of post-ERCP pancreatitis: Results of a controlled prospective study
27. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP
28. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography
29. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: Results of a randomized study
30. Prophylactic effect of somatostatin on post-ERCP pancreatitis: A randomized controlled trial
31. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography
32. Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis
33. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis
34. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice
35. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography
36. Endoscopic diagnosis and therapy of unexplained (idiopathic) acute pancreatitis
37. Detection of gall stones after acute pancreatitis
38. Usefulness of endoscopic ultrasonography in patients with "idiopathic" acute pancreatitis
39. Endoscopic ultrasonography in the evaluation of idiopathic acute pancreatitis
40. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis
41. Biliary tract strictures after orthotopic liver transplantation: Diagnosis and management
42. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation
43. Diagnostic and therapeutic endoscopic retrograde cholangiography after liver transplantation
44. Endoscopic management of postoperative biliary complications in orthotopic liver transplantation
45. Endoscopic therapy of anastomotic bile duct strictures occurring after liver transplantation
46. Efficacy of endoscopic management of anastomotic biliary strictures after hepatic transplantation
47. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer
48. Symptom relief and quality of life after stenting for malignant bile duct obstruction
49. A study of carboptatin-coated tube for the unresectable cholangiocarcinoma
50. Randomized trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin
51. Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid
52. A combination of ciprofloxacin and rowachol does not prevent biliary stent occlusion
53. In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage
54. Is prophylactic ciprofloxacin effective in delaying biliary stent blockage?
55. Peroral cholangiopancreatoscopy (PCPS) under duodenoscopic guidance
56. Long-term follow-up after treatment of Mirizzi syndrome by peroral cholangioscopy
57. Limitation of percutaneous transhepatic cholangioscopy for the diagnosis of the intramural extension of bile duct carcinoma
58. Cholangioscopic differentiation of biliary strictures and polyps
59. Tumor vessel: A valuable cholangioscopic clue of malignant biliary stricture